BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28264157)

  • 1. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
    ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
    Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
    Pustulka SM; Ling K; Pish SL; Champion JA
    ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Corona Formation Impacts Nanomaterials as Drug Carriers.
    Gupta MN; Roy I
    Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
    Yang K; Mesquita B; Horvatovich P; Salvati A
    Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
    Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
    ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome protein corona characterization as a new approach in nanomedicine.
    Capriotti AL; Cavaliere C; Piovesana S
    Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers.
    Berrecoso G; Crecente-Campo J; Alonso MJ
    Drug Deliv Transl Res; 2020 Jun; 10(3):730-750. PubMed ID: 32152965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
    Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
    Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
    Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
    Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
    Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
    Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of formation of protein corona onto nanoparticles.
    Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
    Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic dendrimers control protein binding and corona formation on liposome nanocarriers.
    Wagner J; Dillenburger M; Simon J; Oberländer J; Landfester K; Mailänder V; Ng DYW; Müllen K; Weil T
    Chem Commun (Camb); 2020 Aug; 56(61):8663-8666. PubMed ID: 32608398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of protein corona and immune cells controls blood residency of liposomes.
    Giulimondi F; Digiacomo L; Pozzi D; Palchetti S; Vulpis E; Capriotti AL; Chiozzi RZ; Laganà A; Amenitsch H; Masuelli L; Peruzzi G; Mahmoudi M; Screpanti I; Zingoni A; Caracciolo G
    Nat Commun; 2019 Aug; 10(1):3686. PubMed ID: 31417080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation.
    Putri AD; Hsu MJ; Han CL; Chao FC; Hsu CH; Lorenz CD; Hsieh CM
    Nanoscale; 2023 Nov; 15(44):17825-17838. PubMed ID: 37850423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Characterization of Protein Corona Formation on Silica Microparticles Using Confocal Laser Scanning Microscopy Combined with Microfluidics.
    Weiss ACG; Krüger K; Besford QA; Schlenk M; Kempe K; Förster S; Caruso F
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):2459-2469. PubMed ID: 30600987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
    Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
    Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.